Literature DB >> 8700532

Deletion mapping identifies loss of heterozygosity at 5p15.1-15.2, 5q11 and 5q34-35 in human male germ cell tumors.

V V Murty1, V E Reuter, G J Bosl, R S Chaganti.   

Abstract

Cytogenetic and loss of heterozygosity (LOH) studies of chromosome 5 in male germ cell tumors (GCTs) previously reported suggested the presence of one or more tumor suppressor genes (TSGs) on this chromosome which may play a role in the development of these tumors. In an attempt to further characterize allelic deletions on chromosome 5, we performed a detailed deletion mapping utilizing 66 normal-tumor DNAs from male GCTs assaying 24 polymorphic markers mapped to both the short and long arms. Thirty-seven (56%) tumors exhibited LOH at one or more loci. Loss of one allele at all informative loci was found in 15 of 37 (40.5%) cases suggesting monosomy of chromosome 5. The pattern of LOH in the remaining 22 (59.5%) tumors revealed regional losses identifying three common sites of deletions at 5p15.1-15.2, 5q11, and 5q34-35, respectively. The distribution of allelic deletions was found to be similar in all histologic subtypes with predominance of monosomy in teratomas. Thus, the present study revealed 2 types of chromosome 5 abnormalities in male GCTs, genetic monosomy and regional deletion, the latter identifying three novel sites of candidate TSGs. These data suggest that loss of genetic information on chromosome 5 plays an important role in male GCT development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8700532

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Allelic loss on chromosome 5q34 is associated with poor prognosis in hepatocellular carcinoma.

Authors:  P Saelee; S Wongkham; V Bhudhisawasdi; B Sripa; S Chariyalertsak; S Petmitr
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-02       Impact factor: 4.553

2.  Cytogenetic profile of primary pituitary germinoma.

Authors:  E Gömöri; D J Halbauer; T Dóczi; E Balázs; P Kajtár; L Pajor
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

3.  A male germ cell tumor-susceptibility-determining locus, pgct1, identified on murine chromosome 13.

Authors:  A J Muller; A K Teresky; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

4.  Disruption of the pelota gene causes early embryonic lethality and defects in cell cycle progression.

Authors:  Ibrahim M Adham; Mahmoud A Sallam; Gerd Steding; Monika Korabiowska; Ulrich Brinck; Sigrid Hoyer-Fender; Changkyu Oh; Wolfgang Engel
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

5.  Crystal structure of the human dual specificity phosphatase 1 catalytic domain.

Authors:  Rajesh Gumpena; George T Lountos; Sreejith Raran-Kurussi; Joseph E Tropea; Scott Cherry; David S Waugh
Journal:  Protein Sci       Date:  2017-11-21       Impact factor: 6.725

6.  PRELI (protein of relevant evolutionary and lymphoid interest) is located within an evolutionarily conserved gene cluster on chromosome 5q34-q35 and encodes a novel mitochondrial protein.

Authors:  Elizabeth J Fox; Sally A Stubbs; Jimmy Kyaw Tun; Jack P Leek; Alexander F Markham; Stephanie C Wright
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

7.  Chromosome 5 allelic losses are early events in tumours of the papilla of Vater and occur at sites similar to those of gastric cancer.

Authors:  A Achille; A Baron; G Zamboni; C Di Pace; S Orlandini; A Scarpa
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

8.  Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change.

Authors:  B Summersgill; H Goker; S Weber-Hall; R Huddart; A Horwich; J Shipley
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

9.  Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model.

Authors:  S W Faulkner; D A Leigh; J W Oosterhuis; H Roelofs; L H Looijenga; M L Friedlander
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.